Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. Agilent aims to ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization ...
Agilent Technologies acquires Biocare Medical for $950M to expand into high-growth pathology and cancer diagnostics, enhancing recurring consumables revenue streams. Agilent trades below historical ...
Agilent Technologies Inc. shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Biocare Medical has been a prominent ...
Agilent Technologies has agreed to acquire pathology solutions provider Biocare Medical in a cash transaction worth $950m. The acquisition will give life sciences firm Agilent control of ...
Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...
Agilent Technologies said Monday it agreed to acquire Biocare Medical for $950 million in cash to expand its pathology portfolio. Biocare’s antibody, reagent and instrument business complements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results